Find News

Filter articles

Showing 2871 to 2880 of 2945 results

Leahy demands Myriad “march-in rights”


Senator Patrick Leahy has urged the US National Institutes of Health to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer.

Ipsen announces acquisition of research partner Syntaxin

France, US18-07-2013

On July 15, French pharmaceutical company Ipsen announced it has closed the acquisition of life sciences company and research partner Syntaxin.

US appeals court refuses Arzerra rehearing


Biotechnology company Genmab A/S announced on July 15 that the US Court of Appeals for the Federal Circuit has refused a request to rehear a case related to its Arzerra product.

Glenmark confirms Vimpat challenge


Pharmaceutical company Glenmark Generics has confirmed that it has filed ANDAs with the US FDA to market generic versions of epilepsy drug Vimpat.

IPAB rejects Monsanto plant patent


India’s Intellectual Property Appellate Board has affirmed that US agricultural company Monsanto cannot obtain a patent covering transgenic plants, two years after it was first rejected.

Australian bid for OxyContin generic dismissed

Australia12-07-2013Legal developments

The Federal Court of Australia has dismissed Spirit Pharmaceutical’s bid to introduce a generic version of painkiller OxyContin.

Greenberg Traurig names new IP co-chair in Boston


US law firm Greenberg Traurig has appointed shareholder Jennifer Camacho as co-chair of its Boston IP group.

Myriad sues Ambry over cancer gene screening tests


Biotech company Myriad Genetics has filed a patent infringement case against Ambry Genetic Corp for allegedly infringing 10 patents related to genetic diagnostic testing.

FDA stings thousands of fake drug sites


The US Food and Drug Administration (FDA) last month seized and shut down 1,677 illegal pharmacy websites selling $41,104,386 worth of fake medicines.

Novartis strikes vaccine licensing deal with Indian biopharma


Novartis has signed a development and licensing agreement with Indian biopharmaceutical company Biological E Limited (BioE) to deliver two vaccines that protect against typhoid and paratyphoid fevers.

Showing 2871 to 2880 of 2945 results